Certainly can't argue with assessing the risks. If there weren't any, the company wouldn't be worth only 95 million.
Paulgf caught much of what I wanted to say about the big difference between DSO and flotation (GL1) spodumene. GL1 can get into production by Q4 2025, which is fast, but they can't complete with WIN & RDT on timelines.
GL1: First Manna assays were returned 28 June 2022. By the 15th December, they'd racked up a 32.7mt resource. Pretty quick work.
And WIN only needs 2mt for DSO.
Keep an eye on ValMax (RDT) for what timeframe you can expect here on the DSO portion of their study.
Agree with you that nickel looks like it deserves a lot of focus, as the drama around Nornickel might help maintain the high price environment we're enjoying currently.
WIN Price at posting:
38.0¢ Sentiment: None Disclosure: Held
